1. Introduction
===============

Infertility, defined as the failure of a couple to achieve pregnancy after 1 year of unprotected, regular sexual intercourse, affects approximately 15% of all couples attempting to conceive a child.^\[[@R1]--[@R3]\]^ It is known to all that male infertility is a multifactorial and multigenetic disease with a complex pathogenesis that involves lifestyle, environmental risk factors, and individual genetic background.^\[[@R4],[@R5]\]^ Studies have shown that genetic abnormalities account for approximately 15% of male infertility.^\[[@R6]\]^ Over the years, a large number of studies focusing on the association between male infertility and folate-related enzyme genetic polymorphisms have been carried out.

Folate is essential in DNA synthesis, RNA synthesis, methylation reactions, and protein synthesis, which contribute to the maintenance of genome integrity.^\[[@R7],[@R8]\]^ Several key enzymes, including methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) are involved in the folate metabolic pathway.^\[[@R9]\]^ MTHFR catalyzes the conversion of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the dominant circulating form of folate. Methionine as a precursor for S-adenosylmethionine, is produced via the transfer of a methyl group from 5-methyltetrahydrofolate, which is catalyzed by MTR and MTRR.^\[[@R10],[@R11]\]^ Variations in the genes encoding the mentioned enzymes could be potential risk factors for male infertility.^\[[@R12]\]^ The single-nucleotide polymorphisms (SNPs) in the mentioned enzyme genes, such as MTHFR gene polymorphisms (*MTHFR* C677T, rs1801133 and *MTHFR* A1298C, rs1801131), a MS gene polymorphism (*MS* A2756G, rs1805087, also known as *MTR* A2756G), and MTRR gene polymorphism (*MTRR* A66G, rs1801394) have been reported frequently. The *MTHFR* C677T and A1298C polymorphisms have been investigated in several previous meta-analyses for their role as risk factors for male infertility. However, the role of *MTR* A2756G and *MTRR* A66G polymorphisms in the folate metabolic pathway has not yet been fully evaluated for association with the risk of male infertility.

To date, a number of studies have investigated the association between MTR *A2756G* and MTRR *A66G* polymorphisms and idiopathic male infertility risk; however, the results remain controversial and previous studies have small patient sample sizes. In 2015, a meta-analysis was performed to explore the association between folate metabolism genes and idiopathic male infertility risk.^\[[@R13]\]^ Six case--control studies involving 1150 cases and 1082 controls were include to assess the association between MTR A2756G polymorphism and idiopathic male infertility risk, and the results showed no association between MTR A2756G polymorphism and idiopathic male infertility risk in both Non-Asian and Asian populations. And no association was observed between *MTR* A2756G polymorphism and non-obstructive azoospermia (NOA) risk, whereas significant association was only observed in oligoasthenoteratozoospermia (OAT) subgroup in the homozygous genetic model. With regard to the *MTRR* A66G mutation, 7 case--control studies involving 1369 cases and 1330 controls were included in the meta-analysis. They did not detect any outstanding association between the A66G mutation and idiopathic male infertility risk in the overall analyses for all of the genetic models, and no significant risks were observed among the NOA and OAT types. However, in the subgroup analysis by ethnicity, an increased risk was observed in Asians but not in Europeans in the homozygous genetic model.^\[[@R13]\]^ In 2016, Karimian and Colagar^\[[@R14]\]^ conducted a meta-analysis of 7 case--control studies including 1724 cases and 1678 controls, and their results demonstrated that the *MTR* A2756G polymorphism is capable of causing idiopathic male infertility susceptibility in both Non-Asian and Asian populations. In 2017, Xu et al^\[[@R15]\]^ conducted a meta-analysis of 7 case--control studies including 1438 cases and 1363 controls, and their results demonstrated that the MTRR A66G polymorphism may be unrelated to idiopathic male infertility in both Non-Asian and Asian populations. And in the stratified analysis by infertility type, the *MTRR* A66G polymorphism may be associated with OAT risk. Subsequently, a series of novel studies have been performed. In addition, the majority of relevant studies in the Chinese population published in local Chinese journals were not included in these meta-analyses. Therefore, to derive a more precise estimation of these associations, an updated meta-analysis based on 12 studies of *MTR* A2756G (2454 cases and 2525 controls) and 14 studies of *MTR* A66G (2620 cases and 2614 controls) was performed.

2. Materials and methods
========================

2.1. Searching strategy
-----------------------

Medline, Embase, Web of Science, CNKI, CBM, VIP, and Wan Fang databases (up to Jun 21, 2019) were searched using the terms: "folate-related enzyme gene," "MTRR or *methionine synthase reductase*," "MTR, MS, or methionine synthase" "polymorphism, mutation, or variant," "male infertility." In addition, the references of reviews and retrieved articles were also searched to identify other relevant publications. The search was limited to studies published in English or Chinese language. The search strategy flowchart is shown in Fig. [1](#F1){ref-type="fig"}. All analyses were based on previous published studies, thus no ethical approval and patient consent are required.
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2.2. Inclusion criteria and exclusion criteria
----------------------------------------------

The studies included in the present meta-analysis were required to meet the following criteria: studies with full text articles, published in English or Chinese; investigating the association between *MTR* A2756G or *MTRR* A66G polymorphism and idiopathic male infertility susceptibility; availability of genotype frequencies or allele frequencies for both cases and controls; case--control studies; sufficient genotype data were available for the estimation of odds ratios (ORs) and 95% confidence intervals (CIs). Studies were excluded for the following reasons: non-case--control studies; duplicated publications, animal studies, reviews, abstracts, and comments; lack of sufficient data for calculating genotype frequency.

2.3. Quality assessment
-----------------------

The quality of the included studies was assessed by the Newcastle-Ottawa Scale (NOS).^\[[@R16]\]^ The NOS contains 8 items for case--control studies. It is categorized into 3 aspects: selection, comparability, and exposure. The methodological quality is judged by a "star" rating system. Selection has a maximum of 4 stars, comparability has a maximum of 2 stars, and exposure has a maximum of 3 stars. Scores ranged from 0 stars (worst) to 9 stars (best). Studies were graded as "high quality" if the score was 7 to 9, "moderate quality" if the score was 4 to 6, and "low quality" if the score was \<3.

2.4. Data extraction strategy
-----------------------------

The following information was extracted from each study by 2 investigators independently: the first author\'s name, year of publication, country, genotyping method; sample size of the study case and control groups; results of the Hardy-Weinberg equilibrium test (HWE). Extracted data were entered into a collection form and checked by a third author. Disagreements were resolved by discussion between the 2 investigators (BY and SD).

2.5. Statistical analysis
-------------------------

The relationships between *MTRR* A66G and *MTR* A2756G gene polymorphism with the idiopathic male infertility risks were analyzed by using 4 models including allele comparison model, dominant model, recessive model, and codominant model. The strength of the association between *MTRR* A66G and *MTR* A2756G gene polymorphism with the idiopathic male infertility risks were assessed by the OR with 95% CI. Chi-square-based *Q* test and the *I*^2^ metric were used to assess heterogeneity between studies. The heterogeneity was considered significant when *P* \< .10 and *I*^2^ \> 50%. If the *P* value for heterogeneity was \<.10 and *I*^2^ \> 50%, the pooled ORs were analyzed using the random-effect model. In contrast, we applied the fixed-effect model if *P* ≥ .10 or *I*^2^ ≤ 50%. The significance of the pooled OR was determined by the *Z*-test, and *P* \< .05 was considered as statistically significant. The Reviewer Manager 5.3 (Cochrane Collaboration, <http://ims.cochrane.org/revman>) and Stata 12.0 (StataCorp LP, College Station, TX, USA) were used for all statistical analyses. Begg test, Egger test, and funnel plots were used to statistically examine any publication bias. Sensitivity analysis was performed to evaluate the stability of the results by sequential removal of each study.

3. Results
==========

3.1. Study characteristics
--------------------------

A total of 376 results were retrieved after first search in Medline, Embase, Web of Science, CNKI, CBM, VIP, and Wan Fang databases. Of these studies, after the first screening, 359 studies were excluded based on inclusion and exclusion criteria. Finally, after our careful selection, 17 case--control studies considering 3269 cases and 3192 controls were included in this meta-analysis. Of these, there were 12 studies of *MTRR* A2756G with 2454 cases and 2525 controls^\[[@R8],[@R9],[@R14],[@R17]--[@R24]\]^ and 14 studies of *MTR* A66G with 2620 cases and 2614 controls.^\[[@R8],[@R9],[@R17]--[@R23],[@R25]--[@R29]\]^ In the studies eligible for *MTRR* A66G, 8 were conducted in Non-Asian populations, and 6 involved Asian populations. For *MTR* A2756G, 6 studies were conducted in Non-Asian populations, and 6 involved Asian populations. The studies were published between 2006 and 2017. The HWE was performed on all of the included studies, and the genotype distributions in the controls for all studies were consistent with the HWE, except for 3 studies. The detailed characteristics of all the included studies are shown in Table [1](#T1){ref-type="table"}. And the quality of studies based on the NOS score is presented in Table [2](#T2){ref-type="table"}.
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Characteristics of studies included in meta-analysis.
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Quality assessment for all of the included studies.
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3.2. Association of the *MTR* A2756G polymorphism with idiopathic male infertility
----------------------------------------------------------------------------------

Twelve studies included 4979 individuals, which totally evaluated the influence of *MTR* A2756G polymorphism on the risk of idiopathic male infertility. Table [3](#T3){ref-type="table"} listed the main results of the meta-analysis of the associations between the A2756G mutation and idiopathic male infertility risk. Figure [2](#F2){ref-type="fig"} shows the meta-analysis results for the allele model (G vs A), additive model (GG vs AA), dominant model (GG + AG vs AA), and recessive model (GG vs AG + AA), for which the *I*^2^ value, representing the among-study heterogeneity, was 52%, 0%, 42%, and 0%, respectively. Thus, random-effects models were applied in the allele model. Overall, the results revealed significant association between the *MTR* A2756G polymorphism and idiopathic male infertility risks (G vs A: OR = 1.18, 95% CI = 1.00--1.40; GG vs AA: OR = 2.03, 95% CI = 1.48--2.77; GG + AG vs AA: OR = 1.16, 95% CI = 1.02--1.32; GG vs AG + AA: OR = 1.97, 95% CI = 1.45--2.68). Sub-group analyses were performed on data stratified by ethnicity, we found that the *MTR* A2756G polymorphism was associated with a significantly increased idiopathic male infertility risk in Non-Asian population, but not in Asian population. In the stratified analysis by infertility type, we observed a significant association between *MTR* A2756G polymorphism and NOA risks, and similar results were observed in OAT risks. Furthermore, these data were further stratified by ethnicity, significant risks were observed between *MTR* A2756G polymorphism and OAT risk in both Non-Asian and Asian populations. However, we found that the *MTR* A2756G polymorphism was associated with a significantly increased NOA risk in Non-Asian population, but not in Asian population.

###### 

Meta-analysis of the association of *MTR* A2756G polymorphism with idiopathic male infertility.

![](medi-98-e18273-g004)
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3.3. Association of the *MTRR* A66G polymorphism with idiopathic male infertility
---------------------------------------------------------------------------------

Fourteen studies included 5234 individuals, which totally evaluated the influence of *MTRR* A66G polymorphism on the risk of idiopathic male infertility. The main results of the meta-analysis on the association between the *MTRR* A66G polymorphism and risk of idiopathic male infertility were listed in detail in Table [4](#T4){ref-type="table"}. Figure [3](#F3){ref-type="fig"} shows the overall meta-analysis results for the allele model (G vs A), additive model (GG vs AA), dominant model (GG + AG vs AA), and recessive model (GG vs AG + AA), for which the *I*^2^ value, representing the among-study heterogeneity, was 47%, 36%, 31%, and 26%, respectively. Thus, random-effects models were applied in the allele model. Overall, the results revealed no significant association between *MTRR* A66G polymorphism and idiopathic male infertility risks (G vs A: OR = 1.06, 95% CI = 0.95--1.19; GG vs AA: OR = 1.20, 95% CI = 0.95--1.51; GG + AG vs AA: OR = 1.05, 95% CI = 0.93--1.19; GG vs AG + AA: OR = 1.13, 95% CI = 0.98--1.31). Sub-group analyses were performed by ethnicity, we observed a significant association between MTRR A66G polymorphism and idiopathic male infertility risks in Asian population in recessive model (GG vs AG + AA: OR = 1.44, 95% CI = 1.09--1.90), whereas there was no significantly elevated infertility risks associated with the MTRR A66G polymorphism and idiopathic male infertility in Non-Asian population in any of the genetic models. Furthermore, in the stratified analysis by infertility type, we observed a significant association between MTRR A66G polymorphism and OAT risks, however, no statistically significant increased risk of NOA was found in any of the genetic models. Furthermore, these data were further stratified by ethnicity, no significant risks were observed between *MTRR* A66G polymorphism and NOA risk both in Non-Asian and Asian populations. However, significant association was observed between *MTRR* A66G polymorphism and OAT risk in Asian population, but not in Non-Asian population.

###### 

Meta-analysis of the association of *MTRR* A66G polymorphism with idiopathic male infertility.
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3.4. Sensitivity analyses and publication bias
----------------------------------------------

No evidence of obvious asymmetry was observed in the funnel plots in any of the models on the 2 SNPs (Figs. [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). In addition, Begg tests and Egger tests were used to calculate the potential publication bias, and no indication of publication bias was identified in the studies on the 2 SNPs (Table [5](#T5){ref-type="table"}). The sensitivity analyses were performed to investigate the pooled ORs through excluding one study each time, and the results showed no individual study had substantial influence on the overall pooled ORs in all genetic models (Figs. [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). That is to say, the results of this meta-analysis are relatively stable.

![Funnel plots for the *MTR* A2756G polymorphism and idiopathic male infertility. (A. Allelic model: G vs A; B. additive model: GG vs AA; C. dominant model: GG + AG vs AA; D. recessive model: GG vs AG + AA).](medi-98-e18273-g008){#F4}

![Funnel plots for the *MTRR* A66G polymorphism and idiopathic male infertility. (A. Allelic model: G vs A; B. additive model: GG vs AA; C. dominant model: GG + AG vs AA; D. recessive model: GG vs AG + AA).](medi-98-e18273-g009){#F5}

###### 

Publication bias test for the *MTR* A2756G and *MTRR* A66G polymorphisms.
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4. Discussion
=============

The folate metabolism pathway plays an important role in DNA methylation, DNA repair, and DNA synthesis.^\[[@R14],[@R30],[@R31]\]^ Abnormal folate metabolism has been proposed as a factor in male infertility. *MTR* and *MTRR* are the key enzymes implicated in the folate metabolic pathways and are crucial for DNA methylation and spermatogenesis.^\[[@R9],[@R32]\]^*MTR* is critical for homocysteine metabolism, and *MTRR* is required to maintain *MTR* in its active state.^\[[@R33]\]^ The SNPs of these folate-related enzymes gene can impair folate absorption or disturb the balance between folate derivatives by impacting the activity, stability, or level of the corresponding enzymes.^\[[@R34]\]^ The mechanisms of pathogenesis may involve changes of enzyme structure and mRNA properties that are due to these folate-related enzymes gene polymorphisms.^\[[@R35]\]^

There is increasing evidence investigating the association between *MTR* A2756G and *MTRR* A66G polymorphisms and risk of idiopathic male infertility. Gava et al^\[[@R18]\]^ reported that the combinatory analysis of the *MTRR* A66G polymorphism did not show difference between cases and controls, and the *MTR* A2756G polymorphism could be an important genetic factor predisposing to idiopathic infertility in Brazilian men. Li et al^\[[@R20]\]^ revealed an association between the SNP A66G in the *MTRR* gene and idiopathic male infertility, no significant association was found between SNP A2756G in the MS gene and idiopathic male infertility risk in Chinese population. However, Farcas et al^\[[@R22]\]^ found there is no significant association of SNP A2756G in the MS gene or SNP A66G in the *MTRR* gene with idiopathic male infertility risk in Romanian population group. Similarly, Kurzawski et al^\[[@R23]\]^ found that the *MTR* A2756G and *MTRR* A66G polymorphism are not major risk factors for non-obstructive idiopathic male infertility in the Polish population. This difference among studies may be due to small sample sizes, study differences in genotyping method or population substructure, or other factors. Despite the fact that several meta-analyses have been performed to evaluate the association between *MTR* A2756G, *MTRR* A66G polymorphisms and risk of idiopathic male infertility, to the best of our knowledge, this is the most updated meta-analysis which included 12 studies of *MTRR* A2756G with 4979 individuals and 14 studies of *MTR* A66G with 5234 individuals. In the present study, significant association was observed between *MTR* A2756G polymorphism and idiopathic male infertility in the overall population. In a subgroup analysis by nationality, we have found a significant association between the *MTR* A2756G polymorphism and idiopathic male infertility in Non-Asians, but not in Asian population, which was consistent with a previous meta-analysis based on Chinese population.^\[[@R36]\]^ Similarly, the *MTR* A2756G polymorphism was significantly associated with NOA and OAT in Non-Asian, but not in Asian population in any of the genetic models. In a more recent meta-analysis by Karimian and Colagar,^\[[@R14]\]^ they have suggested that *MTR* A2756G polymorphism was associated with idiopathic male infertility in both Non-Asian and Asian populations. In addition, they have found that *MTR* A2756G polymorphism significantly associated with NOA and OAT risk in the overall population. As regard to the *MTRR* A66G polymorphism, no significant association was found with idiopathic male infertility in the overall population, however, we have observed that the *MTRR* A66G polymorphism associated with OAT in Asians but not Non-Asians. A previous meta-analysis conducted by Xu et al^\[[@R10]\]^ have suggested *MTRR* A66G polymorphism was not associated with idiopathic male infertility in both Non-Asian and Asian populations, however, in a subgroup analysis by infertility type, significant association was found between *MTRR* A66G polymorphism and OAT. A more recent meta-analysis conducted by Shi et al^\[[@R37]\]^ have suggested *MTRR* A66G polymorphism was significantly associated with idiopathic male infertility in Asian populations. The present study, however, has several advantages compared with the previous meta-analyses. First, more recently-published studies were included in the present meta-analysis, which may underscore the reliability of our findings. Second, Chinese database were searched to more comprehensively assess studies in Chinese populations. Third, the present study added additional subgroup analyses by ethnicity to evaluate the relationship of the 2 SNPs with NOA and OAT. These advantages allowed us to more precisely assess the *MTR* A2756G, *MTRR* A66G polymorphisms and idiopathic male infertility risk associations than previous meta-analyses.

Some limitations of the present study should be considered when interpreting the results. First, for subgroup analysis, the number of included studies was relatively small, therefore, limited data were available. Second, we did not estimate the potential gene--gene and gene--environment interactions due to the lack of information available in the original studies. Third, other clinical data, such as sources of control, subject age, and semen quality, were not considered here due to a lack of information. Finally, our meta-analysis was based on published articles, and there was no sufficient data for adjustment for individual level factors including diet, obesity, and smoking, which might affect the genetic effect.

5. Conclusion
=============

In summary, this meta-analysis provides evidence that the *MTR* A2756G polymorphism may contribute to genetic susceptibility to the risk of idiopathic male infertility in Non-Asian, but not to Asian population. The *MTRR* A66G polymorphism is associated with risk for OAT in Asian, but not in Non-Asian population. Nevertheless, more large sample and representative population-based cases and well-matched controls are needed to validate our results.
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